Menu
Currency
GWAS Study

Human longevity is influenced by many genetic variants: evidence from 75,000 UK Biobank participants.

Pilling LC, Atkins JL, Bowman K et al.

27015805 PubMed ID
GWAS Study Type
65808 Participants
117 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

PL
Pilling LC
AJ
Atkins JL
BK
Bowman K
JS
Jones SE
TJ
Tyrrell J
BR
Beaumont RN
RK
Ruth KS
TM
Tuke MA
YH
Yaghootkar H
WA
Wood AR
FR
Freathy RM
MA
Murray A
WM
Weedon MN
XL
Xue L
LK
Lunetta K
MJ
Murabito JM
HL
Harries LW
RJ
Robine JM
BC
Brayne C
KG
Kuchel GA
FL
Ferrucci L
FT
Frayling TM
MD
Melzer D
Chapter II

Abstract

Summary of the research findings

Variation in human lifespan is 20 to 30% heritable in twins but few genetic variants have been identified. We undertook a Genome Wide Association Study (GWAS) using age at death of parents of middle-aged UK Biobank participants of European decent (n=75,244 with father's and/or mother's data, excluding early deaths). Genetic risk scores for 19 phenotypes (n=777 proven variants) were also tested. In GWAS, a nicotine receptor locus(CHRNA3, previously associated with increased smoking and lung cancer) was associated with fathers' survival. Less common variants requiring further confirmation were also identified. Offspring of longer lived parents had more protective alleles for coronary artery disease, systolic blood pressure, body mass index, cholesterol and triglyceride levels, type-1 diabetes, inflammatory bowel disease and Alzheimer's disease. In candidate analyses, variants in the TOMM40/APOE locus were associated with longevity, but FOXO variants were not. Associations between extreme longevity (mother >=98 years, fathers >=95 years, n=1,339) and disease alleles were similar, with an additional association with HDL cholesterol (p=5.7x10-3). These results support a multiple protective factors model influencing lifespan and longevity (top 1% survival) in humans, with prominent roles for cardiovascular-related pathways. Several of these genetically influenced risks, including blood pressure and tobacco exposure, are potentially modifiable.

63,775 British middle-aged individuals

Chapter III

Study Statistics

Key metrics and study information

65808
Total Participants
GWAS
Study Type
Yes
Replicated
2,033 individuals
Replication Participants
European
Ancestry
U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.